Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Detlef Schlöndorff is active.

Publication


Featured researches published by Detlef Schlöndorff.


Journal of Immunology | 2012

Myeloid Cell-Derived Hypoxia-Inducible Factor Attenuates Inflammation in Unilateral Ureteral Obstruction-Induced Kidney Injury

Hanako Kobayashi; Victoria Gilbert; Qingdu Liu; Pinelopi P. Kapitsinou; Travis L. Unger; Jennifer Rha; Stefano Rivella; Detlef Schlöndorff; Volker H. Haase

Renal fibrosis and inflammation are associated with hypoxia, and tissue pO2 plays a central role in modulating the progression of chronic kidney disease. Key mediators of cellular adaptation to hypoxia are hypoxia-inducible factor (HIF)-1 and -2. In the kidney, they are expressed in a cell type-specific manner; to what degree activation of each homolog modulates renal fibrogenesis and inflammation has not been established. To address this issue, we used Cre-loxP recombination to activate or to delete both Hif-1 and Hif-2 either globally or cell type specifically in myeloid cells. Global activation of Hif suppressed inflammation and fibrogenesis in mice subjected to unilateral ureteral obstruction, whereas activation of Hif in myeloid cells suppressed inflammation only. Suppression of inflammatory cell infiltration was associated with downregulation of CC chemokine receptors in renal macrophages. Conversely, global deletion or myeloid-specific inactivation of Hif promoted inflammation. Furthermore, prolonged hypoxia suppressed the expression of multiple inflammatory molecules in noninjured kidneys. Collectively, we provide experimental evidence that hypoxia and/or myeloid cell-specific HIF activation attenuates renal inflammation associated with chronic kidney injury.


Kidney International | 2010

Innate immune receptors and autophagy: implications for autoimmune kidney injury

Hans-Joachim Anders; Detlef Schlöndorff

Inflammation is the immune systems response to infectious or noninfectious sources of danger. Danger recognition is facilitated by various innate immune receptor families including the Toll-like receptors (TLRs), which detect danger signals in extracellular and intracellular compartments. It is an evolving concept that renal damage triggers intrarenal inflammation by immune recognition of molecules that are being released by dying cells. Such danger-associated molecules act as immunostimulatory agonists to TLRs and other innate immune receptors and induce cytokine and chemokine secretion, leukocyte recruitment, and tissue remodeling. As a new entry to this concept, autophagy allows stressed cells to reduce intracellular microorganisms, protein aggregates, and cellular organelles by moving and subsequently digesting them in autophagolysosomes. Within the autophagolysosome, endogenous molecules and danger-associated molecules may be presented to TLRs or loaded onto the major histocompatibility complex and presented as autoantigens. Here we discuss the current evidence for the danger signaling concept in autoimmune kidney injury and propose that autophagy-related processing of self-proteins provides a source of immunostimulatory molecules and autoantigens. A better understanding of danger signaling should enable us to unravel yet unknown triggers for renal immunopathology and progressive kidney disease.


American Journal of Kidney Diseases | 2001

Expression of chemokines and chemokine receptors during human renal transplant rejection

Stephan Segerer; Yan Cui; Frank Eitner; Tracy Goodpaster; Kelly L. Hudkins; Matthias Mack; Jean-Pierre Cartron; Yves Colin; Detlef Schlöndorff; Charles E. Alpers


Kidney International | 2003

DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.

Debra F. Higgins; David W.P. Lappin; Niamh E. Kieran; Hans J. Anders; R. W. G. Watson; Frank Strutz; Detlef Schlöndorff; Volker H. Haase; John M. Fitzpatrick; Catherine Godson; Hugh R. Brady


Archive | 2001

Antibody and chemokine constructs and their use in the treatment of infections and immunological diseases

Matthias Mack; Detlef Schlöndorff; Michael Spring


Archive | 2001

Bispecific antibody and chemokine receptor constructs

Matthias Mack; Detlef Schlöndorff; Michael Spring


Nephrology Dialysis Transplantation | 2007

Expression of the chemokine receptor CCR1 in human renal allografts

Verena Mayer; Kelly L. Hudkins; Florian Heller; Holger Schmid; Matthias Kretzler; Ulrike Brandt; Hans-Joachim Anders; Heinz Regele; Peter J. Nelson; Charles E. Alpers; Detlef Schlöndorff; Stephan Segerer


Archive | 2000

Ccr5 binding antibody constructs and their use for treating autoimmune diseases

Matthias Mack; Detlef Schlöndorff


Archive | 2000

Antibody and chemokine constructs and their use for treating autoimmune diseases

Matthias Mack; Detlef Schlöndorff


Kidney International | 2017

The changing of the guard: the past, the present, and the future of Kidney International

Detlef Schlöndorff

Collaboration


Dive into the Detlef Schlöndorff's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Camillo Carrara

University of Washington Medical Center

View shared research outputs
Top Co-Authors

Avatar

Frank Eitner

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heinz Regele

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jennifer Rha

University of Pennsylvania

View shared research outputs
Researchain Logo
Decentralizing Knowledge